Displaying 61 - 72 of 119
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Obesity: what do we need to know and why?

Obesity: what do we need to know and why?

Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion

Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Treatment strategies for improvement of NAFLD/NASH

Treatment strategies for improvement of NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Live discussion

Live discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

Webcasts
View
Cirrhosis & Complications
Modulating systemic inflammation: how does Albumin work?

Modulating systemic inflammation: how does Albumin work?

Webcasts
View
Cirrhosis & Complications
How do patients benefit from Albumin?

How do patients benefit from Albumin?

Webcasts
View
Displaying 61 - 72 of 119